Skip to content

Medical emergency? What to do

Experimental drug shrinks advanced skin cancer

3-RXPublished April 16, 20082 min read

Key points

  • An experimental drug designed to block a specific cell-signaling pathway has been shown in a small trial to shrink tumors in patients with advanced basal cell carcinoma, researchers said on Monday.
  • Most cases are easy to treat when detected early, but in rare instances the cancer is resistant to treatment, causing damage to skin and sometimes invading bone and cartilage.
  • Genentech Inc and Curis Inc are developing GDC-0449, which is designed to block the Hedgehog pathway.
  • Abnormal activation of the Hedgehog signaling pathway because of mutations in two cell surface receptors is the cause of most basal cell carcinomas.

An experimental drug designed to block a specific cell-signaling pathway has been shown in a small trial to shrink tumors in patients with advanced basal cell carcinoma, researchers said on Monday.

Basal cell carcinoma, a type of non-melanoma skin cancer, is the most common form of cancer, with about a million new cases estimated in the United States each year.

Most cases are easy to treat when detected early, but in rare instances the cancer is resistant to treatment, causing damage to skin and sometimes invading bone and cartilage.

This first trial in humans of the once-daily oral compound, known as GDC-0449, showed that out of nine treated patients, two had shrinkage of their tumors as shown by a CAT scan, four had shrinkage or improvement of their tumors by clinical exam, two had prolonged periods without tumor growth, and one had significant tumor growth.

"We currently do not have any treatments that can effectively slow tumor growth in these advanced patients. This finding has enormous implications in this population," said Dr. Daniel Von Hoff, trial investigator and chief medical officer for the Scottsdale Clinical Research Institute in Arizona.

Genentech Inc and Curis Inc are developing GDC-0449, which is designed to block the Hedgehog pathway.

The Hedgehog ligands are a family of proteins that are important in tissue growth and repair.

Abnormal activation of the Hedgehog signaling pathway because of mutations in two cell surface receptors is the cause of most basal cell carcinomas.

"The drug has been extremely well tolerated," Von Hoff told a meeting of the American Association for Cancer Research.

"Some patients lose a sense of taste, and there has been a small amount of hair loss and weight loss, but the toxicity has been mild."

Curis said in a statement that Genentech expects to initiate a Phase II clinical trial in advanced basal cell carcinoma during the second half of 2008.

The content on this site is for information only and is not a substitute for professional medical advice, diagnosis or treatment. Drug information pages are an archive and may be out of date: always follow your prescriber, your pharmacist and the current product label. In an emergency, call 911.

Keep reading

Brain

Italy court ruling links mobile phone use to tumor

Italy's supreme court has upheld a ruling that said there was a link between a business executive's brain tumor and his heavy mobile phone usage, potentially opening the door to further legal claims. The court's…

2 min read

When to get help

Reading is for later. These need care now.

Call 911 or go to an emergency department if you or someone with you has any of these:

  • Chest pain or pressureEspecially with breathlessness, sweating or pain in the arm, jaw or back. It can be a heart attack.
  • Face drooping, arm weakness, slurred speechSigns of a stroke. Note the time they started: treatment works best within hours.
  • Severe trouble breathingIncluding a severe allergic reaction with swelling of the lips, tongue or throat.
  • Thoughts of suicideCall or text 988 (Suicide & Crisis Lifeline, US) any time, day or night.

Outside the US, call your local emergency number.

See a doctor within days

  1. 01A new lump, or a sore that does not healMost lumps are harmless, but anything that grows or lasts more than a few weeks should be checked.
  2. 02Unexplained weight loss or lasting fatigueLosing weight without trying, or tiredness that does not lift, can have many causes worth finding.
  3. 03A new medicine and new symptomsSide effects and interactions are common. Ask your pharmacist or prescriber before you stop anything.

General guidance only. If you are unsure how urgent a symptom is, call your doctor or a nurse advice line.